Evofem Drug Patent Portfolio
Evofem owns 2 orange book drugs protected by 16 US patents Given below is the list of Evofem's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12280037 | Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof | 11 Dec, 2041 | Active |
| US11684607 | Secnidazole for use in the treatment of bacterial vaginosis | 16 Sep, 2035 | Active |
| US10335390 | Secnidazole for use in the treatment of bacterial vaginosis | 04 Sep, 2035 | Active |
| US10682338 | Secnidazole for use in the treatment of bacterial vaginosis | 04 Sep, 2035 | Active |
| US10849884 | Secnidazole for use in the treatment of bacterial vaginosis | 04 Sep, 2035 | Active |
| US10857133 | Secnidazole for use in the treatment of bacterial vaginosis | 04 Sep, 2035 | Active |
| US11000507 | Secnidazole for use in the treatment of bacterial vaginosis | 04 Sep, 2035 | Active |
| US11000508 | Secnidazole for use in the treatment of trichomoniasis | 04 Sep, 2035 | Active |
| US11020377 | Secnidazole for use in the treatment of bacterial vaginosis | 04 Sep, 2035 | Active |
| US11324721 | Secnidazole for use in the treatment of trichomoniasis | 04 Sep, 2035 | Active |
| US11602522 | Secnidazole for use in the treatment of sexually transmitted infection | 04 Sep, 2035 | Active |
| US10568855 | Compositions and methods for enhancing the efficacy of contraceptive microbicides | 15 Mar, 2033 | Active |
| US11337989 | Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound | 15 Mar, 2033 | Active |
| US11439610 | Compositions and methods for enhancing the efficacy of contraceptive microbicides | 15 Mar, 2033 | Active |
| US11992472 | Compositions and methods for enhancing the efficacy of contraceptive microbicides | 15 Mar, 2033 | Active |
| US6706276 | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa | 06 Mar, 2024 | Expired |
Latest Legal Activities on Evofem's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Evofem.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Letter from FDA or Dept of Agriculture re PTE application | 28 Aug, 2025 | US6706276 |
| Change in Power of Attorney (May Include Associate POA) | 20 Jun, 2025 | US11000508 |
| Email Notification | 20 Jun, 2025 | US11000508 |
| Recordation of Patent eGrant | 22 Apr, 2025 | US12280037 |
| Patent eGrant Notification | 22 Apr, 2025 | US12280037 |
| Email Notification | 22 Apr, 2025 | US12280037 |
| Recordation of Patent Grant Mailed | 22 Apr, 2025 | US12280037 |
| Patent Issue Date Used in PTA Calculation | 22 Apr, 2025 | US12280037 |
| Mail Patent eGrant Notification | 22 Apr, 2025 | US12280037 |
| Email Notification | 03 Apr, 2025 | US12280037 |
| Issue Notification Mailed | 02 Apr, 2025 | US12280037 |
| Dispatch to FDC | 19 Mar, 2025 | US12280037 |
| Application Is Considered Ready for Issue | 19 Mar, 2025 | US12280037 |
| Issue Fee Payment Received | 18 Mar, 2025 | US12280037 |
| Issue Fee Payment Verified | 18 Mar, 2025 | US12280037 |
Evofem's Family Patents
Evofem drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 32.3% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Evofem Drug List
Given below is the complete list of Evofem's drugs and the patents protecting them.
1. Phexxi
Phexxi is protected by 5 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10568855 | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
15 Mar, 2033
(6 years from now)
| Active |
| US11337989 | Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound |
15 Mar, 2033
(6 years from now)
| Active |
| US11439610 | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
15 Mar, 2033
(6 years from now)
| Active |
| US11992472 | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
15 Mar, 2033
(6 years from now)
| Active |
| US6706276 | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
06 Mar, 2024
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Phexxi's drug page
2. Solosec
Solosec is protected by 11 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12280037 | Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof |
11 Dec, 2041
(15 years from now)
| Active |
| US11684607 | Secnidazole for use in the treatment of bacterial vaginosis |
16 Sep, 2035
(9 years from now)
| Active |
| US10335390 | Secnidazole for use in the treatment of bacterial vaginosis |
04 Sep, 2035
(9 years from now)
| Active |
| US10682338 | Secnidazole for use in the treatment of bacterial vaginosis |
04 Sep, 2035
(9 years from now)
| Active |
| US10849884 | Secnidazole for use in the treatment of bacterial vaginosis |
04 Sep, 2035
(9 years from now)
| Active |
| US10857133 | Secnidazole for use in the treatment of bacterial vaginosis |
04 Sep, 2035
(9 years from now)
| Active |
| US11000507 | Secnidazole for use in the treatment of bacterial vaginosis |
04 Sep, 2035
(9 years from now)
| Active |
| US11000508 | Secnidazole for use in the treatment of trichomoniasis |
04 Sep, 2035
(9 years from now)
| Active |
| US11020377 | Secnidazole for use in the treatment of bacterial vaginosis |
04 Sep, 2035
(9 years from now)
| Active |
| US11324721 | Secnidazole for use in the treatment of trichomoniasis |
04 Sep, 2035
(9 years from now)
| Active |
| US11602522 | Secnidazole for use in the treatment of sexually transmitted infection |
04 Sep, 2035
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solosec's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List